Next 10 |
Sharps Technology (NASDAQ: STSS) , a medical-device company, has filed forms with the U.S. Securities and Commission to enter into subscription agreements with certain institutional investors. The agreement calls for the company to issue and sell to the investors 2,239,000 shares of common stock,...
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has made the first shipment of its 1mL and 3mL ...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is pleased to invite investors to a webinar...
2024-06-14 06:02:00 ET Why New Investors Should Look Into Investing in Penny Stocks Penny stocks offer an intriguing entry point for new investors looking to tap into the stock market without a substantial initial investment. These stocks, typically priced under $5, allow individuals to...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $129.61 on volume of 255,610,868 shares Longeveron Inc. (LGVN) rose 48.6% to $2.69 on volume of 190,987,878 shares PROSHARES TRUST (SQQQ) fell 1.6% to $8.54 on volume of 116,711,722 shares Tesl...
A look at the top 10 most actives in the United States Sharps Technology Inc. (STSS) rose 39.8% to $0.4185 on volume of 56,031,365 shares Nuburu Inc. (BURU) fell 36.1% to $0.0933 on volume of 49,471,677 shares BioRestorative Therapies Inc (BRTX) rose 66.7% to $2.25 on volume of 46,968,012...
2024-06-13 08:36:56 ET More on Sharps Technology, Inc. Sharps Technology jumps on $200M sales agreement for syringes with Nephron Pharma Financial information for Sharps Technology, Inc. Read the full article on Seeking Alpha For further details see: Shar...
Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track for expected prefillable syringe product shipments to begin by Q2 of 2025. ...
ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (Nasdaq:SNGX) and Sharps Technology Inc. (Nasdaq:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (E...
Sharps Technology (NASDAQ: STSS) , a medical device company, has announced a Reg A+ warrant inducement offering. The offering, which was announced earlier this week, is estimated to reach approximately $2.2 million. The company has filed the required forms for the offering with the U.S. Security ...
News, Short Squeeze, Breakout and More Instantly...
Sharps Technology Inc. Company Name:
STSS Stock Symbol:
NASDAQ Market:
Sharps Technology Inc. Website:
Sharps Technology (NASDAQ: STSS) , a medical-device company, has filed forms with the U.S. Securities and Commission to enter into subscription agreements with certain institutional investors. The agreement calls for the company to issue and sell to the investors 2,239,000 shares of common stock,...
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has made the first shipment of its 1mL and 3mL ...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is pleased to invite investors to a webinar...